Continuous intravenous intradialysis versus intravenous postdialysis erythropoietin therapy in chronic haemodialysis patients: a randomized, controlled, crossover study | Zendy

José Luis Rocha | Zendy; M.A. Gentil | Zendy; M Gili | Zendy; Lee Jae Gil | Zendy; Virginia Cabello | Zendy; Gabriel Bernal | Zendy

Open Access

Continuous intravenous intradialysis versus intravenous postdialysis erythropoietin therapy in chronic haemodialysis patients: a randomized, controlled, crossover study

Author(s) -

José Luis Rocha,

M.A. Gentil,

M Gili,

Lee Jae Gil,

Virginia Cabello,

Gabriel Bernal

Publication year - 1998

Publication title -

nephrology dialysis transplantation

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/13.1.89

Subject(s) - medicine , erythropoietin , intravenous bolus , bolus (digestion) , hemodialysis , erythropoiesis , intravenous therapy , kidney disease , anesthesia , crossover study , surgery , anemia , placebo , alternative medicine , pathology

Subcutaneous recombinant human erythropoietin seems to be more effective than intravenous administration. Local pain, however, may diminish patient compliance with the subcutaneous route. Recently continuous intravenous intradialysis administration of rHuEpo has been reported to be more efficacious in stimulating erythropoiesis than the usual postdialysis intravenous bolus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research